Evaluation of effectiveness of osteoporosis treatment in patient with pachydermoperiostosis according to densitometric findings Michał Waszczykowski , Jarosław Fabiś , Tomasz Jacek Zwierzchowski, Elżbieta Waszczykowska Ortop Traumatol Rehabil 2013; 15(1):99-105 ICID: 1032795
Article type: Case report
IC™ Value: 1.80
Abstract provided by Publisher
This study presents the outcome of osteoporosis treatment in a 29-year-old male patient with full-blown Touraine-Solente-Gole syndrome. His first DXA densitometry of the proximal femur demonstrated severe osteoporosis (BMD 0.628 g/cm2; T-score -3.84 SD, Z-score -3.37 SD). Bisphosphonate treatment (alendronate 70 mg once weekly) produced considerable clinical improvement during a 36-month follow-up. A follow-up densitometry showed a reduction of the osteoporotic indices (BMD 0.665 g/cm2; T-score -3.54 SD, Z-score -2.93 SD). These findings indicate that it is necessary to treat osteoporosis in pachydermoperiostosis and prevent pathologic bone fractures in these patients.